We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results:1-10 of 15

Why combatting cyber-crime is critical for life science companies
  • Gowling WLG
  • USA
  • April 27 2017

Biotech and pharmaceutical firms hold vast amounts of valuable data and information making them prime targets for cyber-attacks - so how are they


Big pharma continues to woo biotech
  • Gowling WLG
  • USA
  • May 8 2008

Large pharmaceutical companies have continued their pursuit of biotech companies in 2008, maintaining a recent trend of big pharma looking to the biotech sector to find new products and technologies.


QLT Inc. up for sale
  • Gowling WLG
  • USA, Canada
  • December 6 2007

On November 27, 2007, Vancouver-based QLT Inc. announced that it has formed a special committee of directors to "review the company's strategic alternatives", which typically means that a company has put itself up for sale.


Market turmoil rocks biotech stocks
  • Gowling WLG
  • USA
  • September 13 2007

The recent turmoil in global stock markets have hit many public companies in the biotech and other life sciences sectors particularly hard.


Isabel Raasch
  • Gowling WLG

Hélène D'Iorio
  • Gowling WLG

Josh Hanet
  • Gowling WLG

Patrick Duxbury
  • Gowling WLG

Michael Herman
  • Gowling WLG

John Norman PhD
  • Gowling WLG